The AAB joined with 32 other leaders in the U.S. biomanufacturing sector calling for the inclusion of the biotechnology provisions in the Fiscal Year 2026 National Defense Authorization Act (NDAA). The letter notes that the National Security Commission on Emerging Biotechnology (NSCEB) concluded that: "Advances in biotechnology represent a paradigm shift in how conflicts can be fought and won. The countries that seize the moment will retain or achieve superpower status. Those that fail to do...

On September 3, 2025, U.S. Senators Todd Young (R-Ind.), Chairman of the National Security Commission on Emerging Biotechnology ( NSCEB )...

The Special Competitive Studies Project hosted the AI+ Biotechnology Summit  today, marking the release of the National Security...